201 related articles for article (PubMed ID: 22697594)
21. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
Natarajan A; Zaman AG; Marshall SM
Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
[TBL] [Abstract][Full Text] [Related]
22. Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
Bae ON
Arch Pharm Res; 2012 Oct; 35(10):1693-9. PubMed ID: 23139119
[TBL] [Abstract][Full Text] [Related]
23. Current state and novel approaches of antiplatelet therapy.
Metharom P; Berndt MC; Baker RI; Andrews RK
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1327-38. PubMed ID: 25838432
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring of tienopyridines or glycoprotein IIb/IIIa-receptor antagonists: simple platelet function tests].
Halbmayer WM
Hamostaseologie; 2004 Aug; 24(3):203-6. PubMed ID: 15314706
[TBL] [Abstract][Full Text] [Related]
25. Resistance to antiplatelet drugs: current status and future research.
Tantry US; Bliden KP; Gurbel PA
Expert Opin Pharmacother; 2005 Oct; 6(12):2027-45. PubMed ID: 16197357
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model.
Liu YO; Wang ZN; Chen CY; Zhuang XH; Ruan CG; Zhou Y; Cui YM
Curr Drug Metab; 2019; 20(13):1060-1072. PubMed ID: 31755383
[TBL] [Abstract][Full Text] [Related]
27. Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.
Steinhubl SR; Schneider DJ; Berger PB; Becker RC
J Thromb Thrombolysis; 2008 Aug; 26(1):8-13. PubMed ID: 17973080
[TBL] [Abstract][Full Text] [Related]
28. Rising like the phoenix?
Plow EF; Das M
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2182-3. PubMed ID: 25231635
[No Abstract] [Full Text] [Related]
29. Advances in antiplatelet therapy.
Jneid H; Bhatt DL
Expert Opin Emerg Drugs; 2003 Nov; 8(2):349-63. PubMed ID: 14661994
[TBL] [Abstract][Full Text] [Related]
30. Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.
Tautz L; Senis YA; Oury C; Rahmouni S
Bioorg Med Chem; 2015 Jun; 23(12):2786-97. PubMed ID: 25921264
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet activity of flavonoid and coumarin drugs.
Zaragozá C; Monserrat J; Mantecón C; Villaescusa L; Zaragozá F; Álvarez-Mon M
Vascul Pharmacol; 2016 Dec; 87():139-149. PubMed ID: 27616636
[TBL] [Abstract][Full Text] [Related]
32. The progress in the research of antiplatelet agents (1995-2017).
Benimana O; Zhao L; Kong Y; Li Z; Xie Z
Future Med Chem; 2017 Jun; 9(10):1087-1110. PubMed ID: 28632424
[TBL] [Abstract][Full Text] [Related]
33. Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.
Jayakumar T; Hsu CY; Khamrang T; Hsia CH; Hsia CW; Manubolu M; Sheu JR
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925802
[TBL] [Abstract][Full Text] [Related]
34. Novel antiplatelet drugs in clinical development.
Ungerer M; Münch G
Thromb Haemost; 2013 Nov; 110(5):868-75. PubMed ID: 24108565
[TBL] [Abstract][Full Text] [Related]
35. Binding and antiplatelet activity of quercetin, rutin, diosmetin, and diosmin flavonoids.
Zaragozá C; Monserrat J; Mantecón C; Villaescusa L; Álvarez-Mon MÁ; Zaragozá F; Álvarez-Mon M
Biomed Pharmacother; 2021 Sep; 141():111867. PubMed ID: 34229245
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol, a phenolic antioxidant with effects on blood platelet functions.
Olas B; Wachowicz B
Platelets; 2005 Aug; 16(5):251-60. PubMed ID: 16011975
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet drugs.
Born G; Patrono C
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S241-51. PubMed ID: 16402110
[No Abstract] [Full Text] [Related]
38. Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic.
Xiang Q; Pang X; Liu Z; Yang G; Tao W; Pei Q; Cui Y
Pharmacol Ther; 2019 Nov; 203():107393. PubMed ID: 31356909
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet and antithrombotic effects of organic nitrates.
Loscalzo J
Am J Cardiol; 1992 Sep; 70(8):18B-22B. PubMed ID: 1529922
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet therapy, new and old.
Puyo CA
Int Anesthesiol Clin; 2004; 42(3):95-102. PubMed ID: 15205642
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
